Factors that affect in vitro measurement of the susceptibility of herpes simplex virus to nucleoside analogues

Journal of Clinical Virology

Volumn 38, Issue 2, 2007, Pages 139-145

  Weinberg, Adriana ^a   Leary, Jeffry J ^b   Sarisky, Robert T ^c   Levin, Myron J ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b GLAXOSMITHKLINE   (United States)

^c Infectious Diseases Research   (United States)

Author keywords

Aciclovir; Antiviral susceptibility testing; Drug resistance; Herpes simplex virus; Penciclovir

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; NUCLEOSIDE ANALOG; PENCICLOVIR;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DIAGNOSIS, MEASUREMENT AND ANALYSIS; DNA HYBRIDIZATION; ENZYME IMMUNOASSAY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LABORATORY; NONHUMAN; PRIORITY JOURNAL; TISSUE CULTURE; VIRUS CULTURE; VIRUS RESISTANCE;

ACYCLOVIR; ANIMALS; ANTIVIRAL AGENTS; CELL CULTURE TECHNIQUES; CERCOPITHECUS AETHIOPS; DRUG RESISTANCE, VIRAL; FIBROBLASTS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNOENZYME TECHNIQUES; INHIBITORY CONCENTRATION 50; NUCLEIC ACID HYBRIDIZATION; PLAQUE ASSAY; VERO CELLS;

EID: 33846256947     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2006.08.023     Document Type: Article

References (16)

1. Chen Y., Scieux C., Garrait V., Socie G., Rocha V., Molina J.M., et al. Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation. Clin Infect Dis 31 4 (2000) 927-935
2. Corey L., Wald A., Patel R., Sacks S.L., Tyring S.K., Warren T., et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 350 1 (2004) 11-20
3. Kriesel J.D., Spruance S.L., Prichard M., Parker J.N., and Kern E.R. Recurrent antiviral-resistant genital herpes in an immunocompetent patient. J Infect Dis 192 1 (2005) 156-161
4. Leary J.J., Wittrock R., Sarisky R.T., Weinberg A., and Levin M.J. Susceptibilities of herpes simplex viruses to penciclovir and acyclovir in eight cell lines. Antimicrob Agents Chemother 46 3 (2002) 762-768
5. Levin M.J., Bacon T.H., and Leary J.J. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients. Clin Infect Dis 39 Suppl. 5 (2004) S248-S257
6. Levin M.J., Weinberg A., Leary J.J., and Sarisky R.T. Development of acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum. Pediatr Infect Dis J 20 11 (2001) 1094-1097
7. Mertz G.J., Loveless M.O., Levin M.J., Kraus S.J., Fowler S.L., Goade D., et al. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group. Arch Intern Med 157 3 (1997) 343-349
8. Nyquist A.C., Rotbart H.A., Cotton M., Robinson C., Weinberg A., Hayward A.R., et al. Acyclovir-resistant neonatal herpes simplex virus infection of the larynx. J Pediatr 124 6 (1994) 967-971
9. Oram R.J., Marcellino D., Strauss D., Gustafson E., Talarico C.L., Root A.K., et al. Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate. J Infect Dis 181 4 (2000) 1458-1461
10. Reyes M., Shaik N.S., Graber J.M., Nisenbaum R., Wetherall N.T., Fukuda K., et al. Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics. Arch Intern Med 163 1 (2003) 76-80
11. Sacks S.L. Famciclovir suppression of asymptomatic and symptomatic recurrent anogenital herpes simplex virus shedding in women: a randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-center trial. J Infect Dis 189 8 (2004) 1341-1347
12. Safrin S., Elbeik T., Phan L., Robinson D., Rush J., Elbaggari A., et al. Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 38 6 (1994) 1246-1250
13. Shin Y.K., Weinberg A., Spruance S., Bernard M., Bacon T.H., Boon R.J., et al. Susceptibility of herpes simplex virus isolates to nucleoside analogues and the proportion of nucleoside-resistant variants after repeated topical application of penciclovir to recurrent herpes labialis. J Infect Dis 187 8 (2003) 1241-1245
14. Weinberg A., Bate B.J., Masters H.B., Schneider S.A., Clark J.C., Wren C.G., et al. In vitro activities of penciclovir and acyclovir against herpes simplex virus types 1 and 2. Antimicrob Agents Chemother 36 9 (1992) 2037-2038
15. Weinberg A., Jabs D.A., Chou S., et al. Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. J Infect Dis 187 5 (2003) 777-784
16. Xu F., Schillinger J.A., Sternberg M.R., Johnson R.E., Lee F.K., Nahmias A.J., et al. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States 1988-1994. J Infect Dis 185 8 (2002) 1019-1024